| Date Filed | Type | Description |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/26/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.1% stake in CareDx Inc |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/10/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Quarterly results |
| 05/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/14/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
SC 13G
| GAGNON SECURITIES LLC reports a 6.2% stake in CareDx, Inc. |
| 02/27/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/27/2023 |
8-K
| Investor presentation, Quarterly results |
| 02/14/2023 |
SC 13G
| Bellevue Asset Management Ltd. reports a 5.9% stake in CAREDX, INC. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2023 |
SC 13G/A
| ALGER ASSOCIATES INC reports a 0.9% stake in CareDx, Inc. |
| 01/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 10.7% stake in AMENDED FILING CAREDX INC |
| 01/09/2023 |
8-K
| Investor presentation|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022 BRISBANE, Calif., January 9, 2023— CareDx, Inc. — The Transplant Company ™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers - today reported preliminary financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter Highlights",
"Corporate Presentation of CareDx, Inc., dated January 2023" |
|
| 12/06/2022 |
8-K
| Quarterly results |
| 11/23/2022 |
8-K
| Quarterly results |
|